Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business
Epidemiology: Non-Small Cell Lung Cancer – Despite Global Efforts to Stop Smoking, Incidence Rates will Remain Unchanged

Epidemiology: Non-Small Cell Lung Cancer – Despite Global Efforts to Stop Smoking, Incidence Rates will Remain Unchanged - new market report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-01-16 01:41:40 - Epidemiology: Non-Small Cell Lung Cancer – Despite Global Efforts to Stop Smoking, Incidence Rates will Remain Unchanged - a new market research report on companiesandmarkets.com

Most people are not diagnosed with lung cancer until the disease has advanced to later-stage illness, making it difficult to treat the cancer successfully and greatly impacting 5-year survival rates for the disease. Smoking cessation is the most effective measure in reducing the risk of non-small cell lung cancer.

For newly diagnosed non-small cell lung cancer in the seven major markets, adults aged 70–74 will have the largest number of total incident cases (80,310 cases), followed by adults ages 65–69 and 75–79 (73,500 cases and 71,300 cases, respectively).

Introduction

Smoking is the leading cause of lung cancer, responsible for 95% of all cases. Global efforts to stop smoking have stabilized over the last decade. Datamonitor epidemiologists expect the number of total incident cases

 

 

of non-small cell lung carcinoma to remain stable in the seven major markets over the next 10 years.

Features and benefits

- Gain insight into market potential, including a robust 10-year epidemiology forecast of non-small cell lung cancer.
- Understand the key epidemiologic risk factors associated with non-small cell lung cancer.

Your key questions answered

- What are the most robust sources for non-small cell lung cancer incidence data?
- How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in incident non-small cell lung cancer cases?

Click for report details: www.companiesandmarkets.com/Market-Report/epidemiology-non-small ..

Browse all Healthcare and Medical Market Research Reports
www.companiesandmarkets.com/healthcare-and-medical-market-resear ..

Browse all Healthcare and Medical Company Profile Reports
www.companiesandmarkets.com/healthcare-and-medical-company-profi ..

Browse all Latest Market Research Reports
www.companiesandmarkets.com/market-research-reports-p9.aspx?prk= ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 500,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest. Companiesandmarkets.com is focused on providing clients with exemplary customer service and a flexible approach to accessing business information. Our team have extensive expertise in the market research industry and are keen to provide clients advice on their research requirements and possible alternative sources of information; a model which provides clients a value for money solution to research.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser